 |
“This study demonstrates how (use) of a
weakly reactive control...alerted the
Red Cross to an undesirable lot
variation,” says Sandy Dickson of the
American Red Cross National Testing
Laboratory, and lead author. These
controls are now required in
pre-qualification batches for all
infectious disease screening assays. More
|
SeraCare offers a wide
range of independent
controls for monitor of
infectious disease
testing.
|
|
 |
“If your lab plans to implement one of
the new HIV Ag/Ab tests, the optimal
sample for new method evaluation set may
be a combination from your own sample
bank and commercial resources,” says Pat
Garrett, Ph.D., senior director of
science and technology at SeraCare. More
|
SeraCare offers several
seroconversion panels to
help your method
evaluation.
|
|
 |
“If your lab does not participate in a
peer review or inter-laboratory program,
you may want to move this kind of audit
up on your priority list,” says Chris
Long, SeraCare's associate product
manager for QC and method evaluation
products. Now, how do you choose? More
|
|
|
|
Purified PBMC Subsets,
off the shelf or
customized. CD19+ B-cells. CD4+
and CD8+ T-cells. Supporting
your discovery and preclinical
research initiatives.
More
HIV Performance Panel WWRB304,
20 members, diverse
geographic locations. Various
subtypes include CRF01_AE and
CRF02_AG. Great tool for
evaluation of HIV detection
assays.
More
Human Male AB,
consistently low endotoxin,
sterile filled, available in 100
mL size. Ideal for research and
biologics manufacturing
applications.
More
Sample Collection Kits,
to support your clinical trial.
SeraCare has experience with a
wide range of collection
methods, and many types of
samples. Logistics from point of
donation to destination.
Processing and analysis as
needed.
Inquire
|
|
|
